Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04628689
Other study ID # FMBSUREC/01092020/Abd El Badei
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date November 20, 2020
Est. completion date December 30, 2020

Study information

Verified date November 2020
Source Beni-Suef University
Contact doaa rashwan
Phone 00201011270763
Email doaa_rashwan@hotmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the optimum concentration of bupivacaine in Paraspinous Sagittal Shift Approach for Quadratus Lumborum Block in hip Surgeries


Description:

With the patient in the lateral decubitus and the block side independent, a curvilinear ultrasound transducer (2-5 MHz) will be directed caudally in a sagittal plane 3-4 cm lateral to the lumbar spinous process of L4, which is almost opposite to the iliac crest, producing a longitudinal scan of the lumbar paravertebral region; and thus identifying the transverse processes of L3 and L4, with PM muscle in-between and erector spinae muscle posteriorly. The probe is shifted slowly to the lateral side until the transverse processes disappear and the QL muscle is evident in its long axis attached caudally to the iliac crest with a characteristic sonographic image of three muscle layers appearing from posterior to anterior as: erector spinae, QL, and PM muscles respectively. After subcutaneous local infiltration with lidocaine at the cephalic end of the probe, the block needle is advanced in a cephalo-caudal direction, through the erector spinae and QL muscles, until it pierces the epimysium of the QL. LA is injected anterior to the QL muscle, observing its spread in a caudal direction towards the iliac crest between the QL and psoas muscles


Recruitment information / eligibility

Status Recruiting
Enrollment 5
Est. completion date December 30, 2020
Est. primary completion date December 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - ASA I and II undergoing hip surgery. Exclusion Criteria: - Contraindications for regional blocks (eg. Patient refusal Infection at the injection site, coagulopathy) allergic reaction to drugs. opium addiction, any drug or substance abuse

Study Design


Related Conditions & MeSH terms


Intervention

Other:
quadratus lumborum block by paraspinous sagittal shift approach
quadratus lumborum block by paraspinous sagittal shift approach

Locations

Country Name City State
Egypt Benisuef univercity Bani Suwayf Benisuef

Sponsors (1)

Lead Sponsor Collaborator
Beni-Suef University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary time to first request of analgesics Postoperative time to first request of analgesics (hours) Postoperative 24 hours